You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca agrees strategic transaction with Almirall in respiratory disease. AstraZeneca has entered an agreement to transfer to the company the rights to Almirall’s respiratory franchise for an initial consideration of $875 million on completion, and up to $1.22 billion in development, launcAlready a subscriber Login You have read all your…
Orion Corporation has signed a European wide marketing and distribution agreement with Marinus Pharmaceuticals for ganaxolone, a GABAA receptor modulator being investigated in multiple rare seizure disorders. Under the terms of the agreement, Orion will have the right to sell and market ganaxoAlready a subscriber Login You have read all your free articles,…
Swedish Dilafor AB and Italian Opocrin S.p.A. have entered into a commercial supply and partnership agreement. In the agreement, Opocrin will concurrently make an investment in Dilafor and be appointed as the main commercial manufacturing partner for Dilafor’s candidate drug tafoxiparin for theAlready a subscriber Login You have read all…
The company has signed an agreement with MTF Biologics, the world’s largest tissue bank, to extend and strengthen its US product offering. The agreement will give the company US rights to two forms of bone graft materials comprised of 100% demineralized bone matrix (DBM), which offer improved oAlready a subscriber…
